279 related articles for article (PubMed ID: 29670349)
1. Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis.
Zhang L; Chang J; Zhao Y; Xu H; Wang T; Li Q; Xing L; Huang J; Wang Y; Liang Q
Int J Nanomedicine; 2018; 13():2051-2064. PubMed ID: 29670349
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo.
Zhang L; Wang T; Li Q; Huang J; Xu H; Li J; Wang Y; Liang Q
Int J Nanomedicine; 2016; 11():2663-73. PubMed ID: 27354796
[TBL] [Abstract][Full Text] [Related]
3. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis.
Gu Y; Tang X; Yang M; Yang D; Liu J
Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415
[TBL] [Abstract][Full Text] [Related]
4. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY
Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813
[TBL] [Abstract][Full Text] [Related]
5. [Preparation and toxicity of triptolide-loaded poly (D,L-lactic acid) nanoparticles].
Liu MX; Dong J; Yang YJ; Yang XL; Xu HB
Yao Xue Xue Bao; 2004 Jul; 39(7):556-60. PubMed ID: 15493850
[TBL] [Abstract][Full Text] [Related]
6. Transdermal delivery of triptolide-phospholipid complex to treat rheumatoid arthritis.
Liu XY; Pei WJ; Wu YZ; Ren FL; Yang SY; Wang X
Drug Deliv; 2021 Dec; 28(1):2127-2136. PubMed ID: 34617835
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tissue distribution study in mice of triptolide-loaded lipid emulsion and accumulation effect on pancreas.
Li X; Mao Y; Li K; Shi T; Yao H; Yao J; Wang S
Drug Deliv; 2016 May; 23(4):1344-54. PubMed ID: 25853479
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumour and immuno-modulation effects of triptolide-loaded polymeric micelles.
Xu L; Chen H; Xu H; Yang X
Eur J Pharm Biopharm; 2008 Nov; 70(3):741-8. PubMed ID: 18761405
[TBL] [Abstract][Full Text] [Related]
9. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ
Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085
[TBL] [Abstract][Full Text] [Related]
10. Study on the efficacy and mechanism of triptolide on treating TNF transgenic mice with rheumatoid arthritis.
Wang S; Zuo S; Liu Z; Ji X; Yao Z; Wang X
Biomed Pharmacother; 2018 Oct; 106():813-820. PubMed ID: 29990875
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.
Zhang C; Peng F; Liu W; Wan J; Wan C; Xu H; Lam CW; Yang X
Int J Nanomedicine; 2014; 9():1049-63. PubMed ID: 24591827
[TBL] [Abstract][Full Text] [Related]
12. [Enhancement by FK506 of triptolide-induced inhibition of expression of COX-2 and iNOS in human rheumatoid arthritis synovial fibroblasts].
Yao HP; Shao XT; Sun WJ; Shao CS; Zhang LH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):277-82. PubMed ID: 12621554
[TBL] [Abstract][Full Text] [Related]
13. Kidney-targeted triptolide-encapsulated mesoscale nanoparticles for high-efficiency treatment of kidney injury.
Deng X; Zeng T; Li J; Huang C; Yu M; Wang X; Tan L; Zhang M; Li A; Hu J
Biomater Sci; 2019 Dec; 7(12):5312-5323. PubMed ID: 31617509
[TBL] [Abstract][Full Text] [Related]
14. FK506 enhances triptolide-induced down-regulation of cyclooxygenase-2, inducible nitric oxide synthase as well as their products PGE2 and NO in TNF-alpha-stimulated synovial fibroblasts from rheumatoid arthritic patients.
Yao H; Zhou J; Li D; Wu N; Bader A; Höxtermann S; Altmeyer P; Brockmeyer NH
Eur J Med Res; 2005 Mar; 10(3):110-6. PubMed ID: 15851377
[TBL] [Abstract][Full Text] [Related]
15. The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle.
Mei Z; Li X; Wu Q; Hu S; Yang X
Pharmacol Res; 2005 Apr; 51(4):345-51. PubMed ID: 15683748
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Cancer Angiogenesis Using Triptolide Nanoparticles.
Wang C; Shan Y; Yang J; Xu X; Zhuang B; Fan Y; Xu W
J Biomed Nanotechnol; 2015 May; 11(5):805-15. PubMed ID: 26349393
[TBL] [Abstract][Full Text] [Related]
17. Cubic and hexagonal liquid crystals as drug carriers for the transdermal delivery of triptolide.
Shan QQ; Jiang XJ; Wang FY; Shu ZX; Gui SY
Drug Deliv; 2019 Dec; 26(1):490-498. PubMed ID: 31081409
[TBL] [Abstract][Full Text] [Related]
18. Triptolide Improves Diabetic Nephropathy by Regulating Th Cell Balance and Macrophage Infiltration in Rat Models of Diabetic Nephropathy.
Guo H; Pan C; Chang B; Wu X; Guo J; Zhou Y; Liu H; Zhu Z; Chang B; Chen L
Exp Clin Endocrinol Diabetes; 2016 Jun; 124(6):389-98. PubMed ID: 27328403
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of triptolide on interleukin-18 and its receptor in rheumatoid arthritis synovial fibroblasts].
Mao XD; Sun SJ; Pei ZY; Zhang LH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jul; 25(7):606-8, 611. PubMed ID: 19737478
[TBL] [Abstract][Full Text] [Related]
20. Triptolide-nanoliposome-APRPG, a novel sustained-release drug delivery system targeting vascular endothelial cells, enhances the inhibitory effects of triptolide on laser-induced choroidal neovascularization.
Lai K; Li Y; Gong Y; Li L; Huang C; Xu F; Zhong X; Jin C
Biomed Pharmacother; 2020 Nov; 131():110737. PubMed ID: 32932044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
